DNTH in the 13F filings
Dianthus Therapeutics Inc · CUSIP 252828108
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 12 Feb 2026
- Managers listing it
- 24
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 1 listed it in both
- Shares listed
- 15,994,462
- combined, among listed positions
- Reported value
- $659m
- combined, at the quarter end
Among the 92 comparable managers: 21 buyers (opened or added shares) and 4 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +1,724,893.
Managers listing DNTH in Q4 2025
24 of 24 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 667,216 shares now+521,050
- Fidelity (FMR LLC)existing position · 6,431,329 shares now+460,691
- Marshall Wace LLPexisting position · 1,008,533 shares now+435,595
- T. Rowe Price Associates Incexisting position · 616,033 shares now+399,898
- ExodusPoint Capital Management LPnew position · 246,788 shares now+246,788
Reductions
- Point72 Asset Management LPexisting position · 1,166,088 shares now-875,872
- Wellington Management Group LLPexisting position · 2,503,190 shares now-74,472
- AllianceBernstein LPexisting position · 834,383 shares now-18,001
New positions and exits
New (8)
Exited (1)
- Balyasny Asset Management LLCwas $17m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q1 2024 | 1 | $2.4m | 1 | 0 |
| Q2 2024 | 1 | $6.5m | 1 | 0 |
| Q3 2024 | 1 | $6.9m | 1 | 0 |
| Q4 2024 | 1 | $6.6m | 1 | 0 |
| Q1 2025 | 2 | $32m | 1 | 0 |
| Q2 2025 | 2 | $33m | 1 | 1 |
| Q3 2025 | 1 | $80m | 1 | 0 |
| Q4 2025 | 6 | $118m | 21 | 4 |
| Q1 2026 | 13 | $1.2bn | 17 | 14 |
| Q2 2026 | 6 | $1.4bn | 9 | 21 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
DNTH and LLY →DNTH and JNJ →DNTH and VRTX →Choose a stock to compare with DNTH →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own DNTH, latest filings →Back to the 13F Explorer →